Side-by-side financials for CABA and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CABA | RVMD |
|---|---|---|
| Market cap | - | $32.71 B |
| US-listed rank | - | #439 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$167.86M | -$1.13B |
| SEC filings | 423 | 782 |
Full pages: Cabaletta Bio, Inc. and Revolution Medicines, Inc., or browse the full rankings.